DBASS3 and DBASS5: databases of aberrant 3'- and 5'-splice sites

被引:45
作者
Buratti, Emanuele [2 ]
Chivers, Martin [1 ]
Hwang, Gyulin [1 ]
Vorechovsky, Igor [1 ]
机构
[1] Univ Southampton, Sch Med, Div Human Genet, Southampton SO16 6YD, Hants, England
[2] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy
关键词
HUMAN-DISEASE GENES; NUCLEOTIDE STRUCTURE; COMPUTATIONAL TOOLS; SPLICING MUTATIONS; RNA; EXON; ACTIVATION; DIVERSITY; JUNCTIONS; PATTERN;
D O I
10.1093/nar/gkq887
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DBASS3 and DBASS5 provide comprehensive repositories of new exon boundaries that were induced by pathogenic mutations in human disease genes. Aberrant 5'- and 3'-splice sites were activated either by mutations in the consensus sequences of natural exon-intron junctions (cryptic sites) or elsewhere ('de novo' sites). DBASS3 and DBASS5 currently contain approximately 900 records of cryptic and de novo 3'- and 5'-splice sites that were produced by over a thousand different mutations in approximately 360 genes. DBASS3 and DBASS5 data can be searched by disease phenotype, gene, mutation, location of aberrant splice sites in introns and exons and their distance from authentic counterparts, by bibliographic references and by the splice-site strength estimated with several prediction algorithms. The user can also retrieve reference sequences of both aberrant and authentic splice sites with the underlying mutation. These data will facilitate identification of introns or exons frequently involved in aberrant splicing, mutation analysis of human disease genes and study of germline or somatic mutations that impair RNA processing. Finally, this resource will be useful for fine-tuning splice-site prediction algorithms, better definition of auxiliary splicing signals and design of new reporter assays. DBASS3 and DBASS5 are freely available at http://www.dbass.org.uk/.
引用
收藏
页码:D86 / D91
页数:6
相关论文
共 37 条
[1]   BETA-THALASSEMIA IN AMERICAN BLACKS - NOVEL MUTATIONS IN THE TATA BOX AND AN ACCEPTOR SPLICE SITE [J].
ANTONARAKIS, SE ;
IRKIN, SH ;
CHENG, TC ;
SCOTT, AF ;
SEXTON, JP ;
TRUSKO, SP ;
CHARACHE, S ;
KAZAZIAN, HH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (04) :1154-1158
[2]   Splicing in action: assessing disease causing sequence changes [J].
Baralle, D ;
Baralle, M .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (10) :737-748
[3]   A SUGGESTED NOMENCLATURE FOR DESIGNATING MUTATIONS [J].
BEAUDET, AL ;
TSUI, LC .
HUMAN MUTATION, 1993, 2 (04) :245-248
[4]  
Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI [10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094, 10.1093/nar/gkl986, 10.1093/nar/gkq1079, 10.1093/nar/gks1195, 10.1093/nar/gkg057]
[5]   Protein diversity from alternative splicing: A challenge for bioinformatics and post-genome biology [J].
Black, DL .
CELL, 2000, 103 (03) :367-370
[6]   Aberrant 5′ splice sites in human disease genes:: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization [J].
Buratti, Emanuele ;
Chivers, Martin ;
Kralovicova, Jana ;
Romano, Maurizio ;
Baralle, Marco ;
Krainer, Adrian R. ;
Vorechovsky, Igor .
NUCLEIC ACIDS RESEARCH, 2007, 35 (13) :4250-4263
[7]   Defective splicing, disease and therapy: searching for master checkpoints in exon definition [J].
Buratti, Emanuele ;
Baralle, Marco ;
Baralle, Francisco E. .
NUCLEIC ACIDS RESEARCH, 2006, 34 (12) :3494-3510
[8]   Translational pathophysiology: a novel molecular mechanism of human disease [J].
Cazzola, M ;
Skoda, RC .
BLOOD, 2000, 95 (11) :3280-3288
[9]  
Cooper DN., 1993, HUMAN GENE MUTATION
[10]   RNA and Disease [J].
Cooper, Thomas A. ;
Wan, Lili ;
Dreyfuss, Gideon .
CELL, 2009, 136 (04) :777-793